secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0001493152-24-033215
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Director George Ng to step down at 2024 annual meeting; Board reduced to 5
--------------------------------------------------------------------------

- George Ng will allow his director term to expire at the Company's 2024 annual shareholder meeting.
- Board size reduced from six to five directors effective the date of the 2024 annual meeting.
- Mr. Ng will continue as a strategic advisor and consultant to the Company.
- Departure not due to any disagreement with Company operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224033215/0001493152-24-033215-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224033215/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033215

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer